Resources Contact Us Home
Modified factor VIII

Image Number 5 for United States Patent #7012132.

Specific amino acid loci of human factor VIII interact with inhibitory antibodies of hemophilia patients who have developed such antibodies after being treated with factor VIII. Modified factor VIII is disclosed in which the amino acid sequence is changed by a substitution at one or more of the specific loci. The modified factor VIII is not inhibited by inhibitory antibodies against the A2 or C2 domain epitopes. The modified factor VIII is useful for hemophiliacs, either to avoid or prevent the action of inhibitory antibodies.

  Recently Added Patents
Glycosyltransferase promoter
Server providing pseudo print preview and final regular preview to device
Method and device for monitoring and analyzing signals
Virtual image display device and manufacturing method of virtual image display device
Semiconductor device and method for manufacturing the same
Method and system for calibrating laser profiling systems
  Randomly Featured Patents
Rotary boat repair apparatus
Apparatus for measuring the intensity and direction of external magnetic fields including power supply and recording units having respective semi-conductor devices
Circuit arrangement for an uninterrupted power supply
Imprinting felt and method of using the same
Method for spray-coating medical devices
Compressor for refrigerating machine
Gel for retarding water flow
Fluorescent detection of DNA damage
Foam panel for construction
Rotatable wet connect for downhole logging devices